UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
9826
Amplify Municipal CEF High Income ETF
YYYM
$1.82M
| $287 | ﹤0.01% |
+14
| New | +$278 |
2026 Q2
0 quarters
|
|
9827
The Frontier Economic Fund
AKAF
$2.95M
| $284 | ﹤0.01% |
9
| – | – |
2025 Q4
2 quarters
|
|
9828
Bristol-Myers Squibb Rights
CELG.RT
$438M
| $281 | ﹤0.01% |
3,121
-1,050
| -25% | -$106 |
2023 Q1
13 quarters
|
|
9829
Enveric Biosciences
ENVB
$6.27M
| $277 | ﹤0.01% |
201
-3,411
| -94% | -$8.19K |
2024 Q1
9 quarters
|
|
9830
Amplify Video Game Tech ETF
GAMR
$38.3M
| $272 | ﹤0.01% |
3
-96
| -97% | -$8.27K |
2025 Q3
3 quarters
|
|
9831
Epsium Enterprise
EPSM
$11.3M
| $269 | ﹤0.01% |
222
-414
| -65% | -$573 |
2025 Q1
5 quarters
|
|
9832
Addex Therapeutics
ADXN
$5.08M
| $268 | ﹤0.01% |
+47
| New | +$309 |
2026 Q2
0 quarters
|
|
9833
Praetorian Acquisition Corp
PTOR
$338M
| $268 | ﹤0.01% |
+27
| New | +$267 |
2026 Q2
0 quarters
|
|
9834
Alvotech Warrant
ALVOW
$1.53M
| $266 | ﹤0.01% |
1,155
+782
| +210% | +$190 |
2025 Q1
5 quarters
|
|
9835
Planet Image International
YIBO
$63.4M
| $266 | ﹤0.01% |
251
-69
| -22% | -$68 |
2024 Q3
7 quarters
|
|
9836
Royalty Management Holding Warrant
RMCOW
$917K
| $265 | ﹤0.01% |
+1,588
| New | +$309 |
2026 Q2
0 quarters
|
|
9837
Fenbo Holdings
FEBO
| $264 | ﹤0.01% |
+296
| New | +$309 |
2026 Q2
0 quarters
|
|
9838
J and Friends Holdings
JF
$17M
| $264 | ﹤0.01% |
247
-203
| -45% | -$206 |
2023 Q1
13 quarters
|
|
9839
Metals Acquisition Corp II
MTAL
$309M
| $264 | ﹤0.01% |
+26
| New | +$263 |
2026 Q2
0 quarters
|
|
9840
Ascentage Pharma
AAPG
$1.41B
| $263 | ﹤0.01% |
15
-109
| -88% | -$2.32K |
2025 Q1
5 quarters
|
|
9841
Veru
VERU
$35M
| $257 | ﹤0.01% |
82
-27,262
| -100% | -$69.4K |
2014 Q4
46 quarters
|
|
9842
NFT Ltd
MI
$28.4M
| $256 | ﹤0.01% |
25
-15
| -38% | -$268 |
2026 Q1
1 quarter
|
|
9843
BTC Development Corp Unit
BDCIU
$233M
| $254 | ﹤0.01% |
25
| – | – |
2025 Q4
2 quarters
|
|
9844
Mannatech
MTEX
$15.7M
| $250 | ﹤0.01% |
48
-437
| -90% | -$2.27K |
2021 Q4
18 quarters
|
|
9845
iShares Climate Conscious & Transition MSCI USA ETF
USCL
$2.82B
| $250 | ﹤0.01% |
+3
| New | +$245 |
2026 Q2
0 quarters
|
|
9846
DELISTED
Columbia Research Enhanced Real Estate ETF
CRED
| $249 | ﹤0.01% |
11
-114
| -91% | -$2.56K |
2024 Q4
6 quarters
|
|
9847
Vantage Corp
VNTG
$13.6M
| $249 | ﹤0.01% |
401
-2,927
| -88% | -$2.24K |
2025 Q2
4 quarters
|
|
9848
Iveda Solutions Warrant
IVDAW
| $248 | ﹤0.01% |
9,903
+3,702
| +60% | +$187 |
2025 Q1
5 quarters
|
|
|
XSPC
9849
Tidal Trust IV VegaShares Space & AI ETF
XSPC
$1.52M
| $247 | ﹤0.01% |
+10
| New | +$236 |
2026 Q2
0 quarters
|
|
9850
Eaton Vance Floating-Rate ETF
EVLN
$1.69B
| $243 | ﹤0.01% |
+5
| New | +$244 |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.